NCT06162624 Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
| NCT ID | NCT06162624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2024-12-09 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2024-12-09 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to adapt an ACT-self-help workbook to the prison setting and determine the feasibility acceptability, and effectiveness of this workbook. Participants can expect to be in the study for 13 weeks.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Reading level of 6th grade or higher determined by the Wide Range Achievement Test * Moderate or severe anxiety and/or depression determined by the Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) * No active self-harm or active suicidal intent * No scheduled transfer or release for at least three months * Must be willing and able to participate, including having permission and ability to use study materials, such as paper and a writing utensil Exclusion Criteria: * Unable to provide informed consent * Active self-harm or suicidal intent * Scheduled transfer or release within three months
Contact & Investigator
Michael Koenigs, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06162624 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06162624 currently recruiting?
Yes, NCT06162624 is actively recruiting participants. Contact the research team at mgmichels@wisc.edu for enrollment information.
Where is the NCT06162624 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06162624 clinical trial?
NCT06162624 is sponsored by University of Wisconsin, Madison. The principal investigator is Michael Koenigs, PhD at University of Wisconsin, Madison. The trial plans to enroll 96 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.